PaxMedica, Inc. PXMD
0.00 USD 0.00 (+0.00%)
Regular-session close
0.0001 Day range 0.0001
0.0001 52-week range 0.02
- YTD
- +400.00%
- 1 year
- +400.00%
News
defenseworld.net ProMetic Life Sciences (OTCMKTS:PFSCF) & PaxMedica (NASDAQ:PXMD) Financial Contrast Profitability This table compares PaxMedica and ProMetic Life Sciences' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets PaxMedica N/A -3,167.89%…
defenseworld.net Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX) Leap Therapeutics (NASDAQ: LPTX - Get Free Report) and PaxMedica (NASDAQ: PXMD - Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will contrast the…
accesswire.com PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, is pleased to…
accesswire.com PaxMedica Secures Immediate Exercise of Warrants TARRYTOWN, NY / ACCESSWIRE / September 3, 2024 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, today…
accesswire.com PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection Company provides update on regulatory progress towards US NDA submission TARRYTOWN, NY / ACCESSWIRE / August 27, 2024 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company…
globenewswire.com PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) ( OTC:PXMD ), a biopharmaceutical company dedicated to advancing treatments for…
globenewswire.com PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological…
globenewswire.com PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness TARRYTOWN, New York, April 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today…
pennystocks.com Choosing Unknown Penny Stocks, 3 Top Tips Penny stocks represent an exciting opportunity for investors looking to expand their portfolios with potentially lucrative, yet cost-effective options. Typically trading below five dollars per share,…
invezz.com Why is PaxMedica (PXMD) stock surging today? PaxMedica (NASDAQ: PXMD) has surged by 92.7% so far on Friday, reflecting the market's positive reaction to the company's announcement of significant progress in its drug development efforts.
invezz.com Why is PaxMedica (PXMD) stock surging today? PaxMedica (NASDAQ: PXMD) has surged by 92.7% so far on Friday, reflecting the market's positive reaction to the company's announcement of significant progress in its drug development efforts.
investorplace.com Why Is PaxMedica (PXMD) Stock Up 93% Today? PaxMedica (NASDAQ: PXMD ) stock is rocketing higher on Friday after the clinical-stage biopharmaceutical company reached a key milestone in drug development. The big news here is the company securing…
globenewswire.com PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today…
globenewswire.com PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today…
accesswire.com PaxMedica Releases Fireside Chat Video with CEO Howard Weisman TARRYTOWN, NY / ACCESSWIRE / December 6, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced the release of a…
accesswire.com PaxMedica Announces Closing of $7.0 Million Public Offering TARRYTOWN, NY / ACCESSWIRE / November 22, 2023 / PaxMedica, Inc. (NASDAQ:PXMD) ("PaxMedica" or the "Company"), a biopharmaceutical company focused on advancing treatments for neurological disorders,…
investorplace.com Why Are Stocks Up Today? Stocks are up today as investors prepare for a Thanksgiving holiday with the latest insight into the economy from the Federal Reserve. The Fed released its meeting minutes yesterday and it offers…
pennystocks.com Penny Stocks To Buy? 5 To Watch Right Now Penny stocks refer to shares of small or micro-cap companies that trade for less than $5 per share. What cheap stocks lack in size and stability, they can potentially make up for in rapid price…
investorplace.com Why Is PaxMedica (PXMD) Stock Up 57% Today? PaxMedica (NASDAQ: PXMD ) stock is climbing higher on Wednesday after the company completed a public offering for its shares. According to a press release from the company, it's offering 5,384,615…
investorplace.com Why Is PaxMedica (PXMD) Stock Down 40% Today? PaxMedica (NASDAQ: PXMD ) stock is cratering today after the company announced a $7 million public offering. The offering consists of 5.38 million shares and warrants to purchase up to 5.38 million…
